Mariano Provencio, oncologist: "In lung cancer, we now have therapies that have changed the landscape of the disease"

Lung cancer remains the leading cause of cancer deaths globally, with significant advancements in treatment highlighted at the ESMO Congress in Madrid. Mariano Provencio discusses the heterogeneity of lung tumors and the need for personalized therapies. Notably, a new drug combination for small cell lung cancer has doubled survival rates, while another approach targets EGFR mutations, improving outcomes for patients with resistance. The shift towards precision medicine emphasizes the importance of molecular diagnostics to tailor treatments effectively. Provencio stresses the necessity of ongoing molecular evaluations as patients' conditions evolve, marking a significant change in cancer treatment strategies.